Activating mutations for the Met tyrosine kinase receptor in human cancer
- 14 October 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 94 (21), 11445-11450
- https://doi.org/10.1073/pnas.94.21.11445
Abstract
Recently, mutations in the Met tyrosine kinase receptor have been identified in both hereditary and sporadic forms of papillary renal carcinoma. We have introduced the corresponding mutations into the met cDNA and examined the effect of each mutation in biochemical and biological assays. We find that the Met mutants exhibit increased levels of tyrosine phosphorylation and enhanced kinase activity toward an exogenous substrate when compared with wild-type Met. Moreover, NIH 3T3 cells expressing mutant Met molecules form foci in vitro and are tumorigenic in nude mice. Enzymatic and biological differences were evident among the various mutants examined, and the somatic mutations were generally more active than those of germ-line origin. A strong correlation between the enzymatic and biological activity of the mutants was observed, indicating that tumorigenesis by Met is quantitatively related to its level of activation. These results demonstrate that the Met mutants originally identified in human papillary renal carcinoma are oncogenic and thus are likely to play a determinant role in this disease, and these results raise the possibility that activating Met mutations also may contribute to other human malignancies.Keywords
This publication has 57 references indexed in Scilit:
- Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.The Journal of cell biology, 1995
- Scatter factor/hepatocyte growth factor is essential for liver developmentNature, 1995
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.JCI Insight, 1993
- Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.The Journal of cell biology, 1993
- Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factorCell, 1991
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cellsBiochemical and Biophysical Research Communications, 1991
- Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTEBiochemical and Biophysical Research Communications, 1991
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987